IntraHub Periodic Safety Update Reports (PSURs): The Ongoing Evaluation of Drug Safety Introduction In pharmacovigilance, the safety of marketed drugs is a continuous priority. Periodic Safety Update Reports (PSURs) are crucial to this process, offering a comprehensive assessment of a d... PSURs Pharmacovigilance May 30, 2025 Our blog
IntraHub Common Pharmacovigilance Compliance Challenges for Pharmaceutical Companies in Nigeria and How to Overcome Them Introduction Pharmacovigilance (PV) is critical for ensuring the safety and efficacy of pharmaceutical products. It involves the detection, assessment, understanding, and prevention of adverse effects... May 18, 2025 Our blog
IntraHub Empowering Patient Safety: Essential Guidelines for Pharmacovigilance Focal Persons in Nigerian Healthcare Facilities While pharmaceutical companies bear significant responsibility for the safety of their products, the commitment to patient well-being extends crucially to healthcare facilities. These institutions for... May 18, 2025 Our blog
IntraHub The Strategic Value of Pharmacovigilance Partnerships for Pharmaceutical Companies in Africa Introduction In today's rapidly evolving pharmaceutical sector, establishing and maintaining a robust pharmacovigilance system has become more critical than ever. For pharmaceutical companies operatin... May 18, 2025 Our blog
IntraHub Why Embracing Pharmacovigilance Compliance is the Key for African Pharma Companies to Compete Globally In the rapidly evolving global pharmaceutical landscape, the spotlight increasingly shines on pharmacovigilance (PV) compliance. Pharmacovigilance (PV)—the science and activities related to detecting,... Apr 12, 2025 Our blog
IntraHub NAFDAC Mandates Bioequivalence Studies for Generic Drugs in Nigeria In an effort to ensure the safety and effectiveness of generic medicines in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has issued a new regulatory directive tha... Apr 12, 2025 Our blog